October's cover article features research from Richard J. A. Goodwin Ph.D. (AstraZeneca), Zoltan Takats Ph.D. (Imperial College London), and Josephine Bunch, Ph.D. (National Physical Laboratory).
"Role of Digital Microfluidics in Enabling Access to Laboratory Automation and Making Biology Programmable" includes original research by Varun B. Kothamachu, Ph.D., Sabrina Zaini and Federico Muffatto of Digi.Bio.
September's SLAS Discovery cover article, "Applications of Functional Genomics for Drug Discovery" by Ami M. Kabadi Ph.D., (Element Genomics), Eoin McDonnell Ph.D. (Element Genomics), Christopher L. Frank Ph.D., (Element Genomics), and Lauren Drowley Ph.D., (UCB Biosciences) reviews how functional genomic tools are better able to understand the biological interplay between genes, improving disease modeling and identifying novel drug targets.
Click through for the official SLAS equality statement and action plan.
The August special issue of SLAS Discovery “High-Content Imaging and Informatics” features a special collection of original research and perspectives curated by guest editors Myles Fennell, Ph.D. and Paul A. Johnston, Ph.D. of The Society of Biomolecular Imaging and Informatics (SBI2).
The August edition of SLAS Technology "Carbohydrate Structure Analysis: Methods and Application" is curated by guest editors Christian Heiss, Ph.D. and Parastoo Azadi, Ph.D. of the University of Georgia's Complex Carbohydrate Research Center.
July’s SLAS Discovery Special Issue Features Three Significant Research Areas on the “Functional Genomics for Target Identification” The July special issue of SLAS Discovery, “Functional Genomics for Target Identification,” features ten articles — four available via open access — focused on three strategic pillars that form the foundation of the functional genomics discipline.
In this issue, Guest Editors Joseph G. McGivern, Ph.D. (Amgen Research, United States) and Mei Ding, Ph.D. (AstraZeneca, Sweden) present three original research papers and one review that reflect the recent advances and continuing challenges in the development and application of assay technologies that are applicable to drug discovery for ion channel targets.
The June issue of SLAS Technology features two related research papers authored by Georges Muller, Ph.D., (SEED Biosciences, Switzerland) the SLAS2019 Ignite Award winner and a top ten 2020 SLAS Innovation Award finalist. Both of Muller’s contributions to the issue include research based on a single-cell cloning method and pipet his teams created to help solve efficiency and regulatory issues.
SLAS Discovery, one of two official journals of SLAS, welcomes Timothy Spicer, Ph.D., as a new Associate Editor. Spicer has served on the SLAS Discovery Editorial Board since 2016 and is currently serving a two-year term as Secretary for the SLAS Board of Directors.
SLAS has released the first two infographics in an ongoing series of tools to help the general public better understand the technical jargon being discussed during the COVID-19 pandemic.
SLAS selected Thi Mui Pham, Ph.D., of the Julius Center for Health Sciences and Primary Care, University Medical Center - Utrecht (Utrecht, Netherlands) as its 2020 SLAS Visiting Graduate Researcher Grant recipient.
Ulri Nicole Lee, Ph.D. candidate, (University of Washington) is the 2020 recipient of the SLAS Graduate Education Fellowship Grant. This is the fifth year the SLAS grant has been awarded to an outstanding student researcher. Lee will receive $100,000 to use toward her research.
Stanton J. Kochanek, Ph.D., David A. Close, Ph.D., Daniel P. Camarco, Ph.D., and Paul A. Johnston, Ph.D., (University of Pittsburgh, PA, USA) disseminate their recent study that shows how incorporating morphology and dead cell readouts into cancer drug screening helps improve the drug selection rate.
In this review, authors Agata Blasiak, Ph.D., Jeffrey Khong, and Theodore Kee (University of Singapore and The N.1 Institute for Health) explain an alternate approach to the current limited and suboptimal big data decision making tools that are used to help medical teams determine a patient's drug and dose recommendation.
The March edition of SLAS Discovery features the cover article, “CRISPR: A Screener’s Guide,” by Carlos le Sage, Ph.D., Steffen Lawo, Ph.D., and Benedict C.S. Cross, Ph.D., (Horizon Discovery, United Kingdom). In their review, the authors discuss how CRISPR-Cas9 systems are being used widely throughout the drug discovery process and the development of new precision medicines.
SLAS Discovery and SLAS Technology announced their annual publication awards honoring articles and authors from editions published in 2019. The awards were officially announced at a special reception held in partnership with SAGE Publishing, on Monday, January 27 at the SLAS2020 International Conference and Exhibition in San Diego.
Brenda Dreier, Chief Operating Officer, has earned her Certified Association Executive (CAE) designation from the American Society of Association Executives. The CAE the highest professional credential in the association industry.
The February special issue of SLAS Discovery, “Advances in Cellular Target Engagement and Target Deconvolution,” features 13 articles focused on multiple aspects and technologies of cellular target engagement.
The first SLAS Technology issue of 2020, “Flexible Analytical Devices for Point-of-Care Testing,” features a series of articles and research reviews highlighting the ever-increasing popularity of wearable technology devices as they apply to disease detection and health monitoring.
Science and technology awards were announced during SLAS2020 International Conference and Exhibition, the annual flagship event of the Society for Laboratory Automation and Screening. Each year SLAS recognizes several exceptional attendees and exhibitors who represent the best of the Society’s programs and mission.
San Diego, CA, USA — Joseph De Rutte, M.S., (University of California Los Angeles, CA, USA) was awarded the SLAS Innovation Award at the SLAS2020 International Conference and Exhibition in San Diego, CA. De Rutte received the award as recognition of his exceptional podium presentation, “High-Throughput Encapsulation and Selection of Cells Based on Antibody Secretion Using Lab-on-a-Particle Technology.”
The annual SLAS New Product Awards were announced at the 9th Annual SLAS International Conference and Exhibition in San Diego, CA, USA.
SLAS Discovery, one of two official journals of SLAS, announced a new tagline for 2020 and beyond. “Advancing the Science of Drug Discovery” will replace “Advancing Life Sciences R&D,” as the official tagline beginning with the just-released January edition of the publication.
SLAS Discovery Kicks Off 2020 with Featured Article, “The National Cancer Institute’s Plated Compound Sets Can Be a Valuable Resource for Academic Researchers”
January’s edition of SLAS Discovery features an analysis of two plated sets of synthetic compounds available from the National Cancer Institute (NCI), and the author’s positive and negative results of using this type of collection in his lab’s research.
Jill Hronek, Director of Marketing Communications
Telephone: +1.630.256.7527, ext. 103